# Endeavor’s threat to IPF incumbents increases after phase 2 win for Hedgehog inhibitor

> **Open Intelligence Dossier** · First detected: 2026-10-09 11:00 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Endeavor’s threat to IPF incumbents increases after phase 2 win for Hedgehog inhibitor&quot; is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Clinical Trials Arena, FirstWord Pharma, Business Wire and Endpoints News. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Clinical Trials Arena | Endeavor’s Phase IIb IPF study of taladegib meets endpoints | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZDBaWk05S0ZDSTRIVm4tOWh5WkJrYlQ1ekNKWGtFYlNMaTUxN3lXU3EzOGg0aWRMaUlEejNBWDNvOTVRcmhlaGpzOFZJNXJzWmRvdEVvU2hyYzlWeEc3ZHlKU1JnTnJJcjFDTzlrNkRqT2VGZXVKMWRYOGJnYmJ3ZmNVbVhueXI4SmVJ?oc=5) |
| FirstWord Pharma | Endeavor to move IPF hopeful into Phase III after mid-stage victory | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFB4ZzVyai1COE5raUdmSHpkVmRwQXpGZlZyd2FqS09jVUc0RXFGODEwemN1WXhuMXRTUDFtVXp0UVhpd2lmUE1EcjhZbEs2T2FNQmNJ?oc=5) |
| Business Wire | Endeavor BioMedicines' WHISTLE-PF Phase 2b Trial of Taladegib Meets Primary and Key Secondary Endpoints in Patients With IPF | [Source Link](https://news.google.com/rss/articles/CBMijAJBVV95cUxNMWU3cDRsY1Y3bWg5MlQ4aFFkMmkxamxCeGhrZnNhZDRXM0trRVBDc2dyR3R3ZkdmT2tTUGN4WnlOQm14LVlWSHhDSUVUWUVDSGVGbkJ2SjF3akRwT3lHOHlOZDZMLThmQ2pCVjJzNlhfVzFkaGJXaU5jWWlpVGtfTTQ4MkxTYklDN041QmZQaUpVdVBwVWc1cGZkWUplTGxGdHBCRHFnUnFLYlJmdkM2YW04M25Zc184b3c5ZFNReVVoSEdUbGdXZEpBbDdoYWVGNjUzaDYtalR6MDhxQUR4eV9WdjN4ZFFaOGZkcTVoeHVseEdtM1JEZjlFaE1vZDNhb09mdFBicV93Vzl5?oc=5) |
| Endpoints News | Endeavor notches major mid-stage trial win, says IPF drug can reverse disease | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxQWTZBTDYxaDlFS21vdWh5V19ieG5VT013SkJBbGh2ODl0WTRxT2xnYzhyMEJwTmV1Y016aEF1Z1N4R01yeHNSczA5MmxGS0JDdDhna2dKX045bzF3czM5MzNtcWExSGtVVUxJQXFkUUltZ0s3X3Z0R2FoRmFSYUlDS1Fkb3hicXJtME1MS01DRTRNX3hZM1c5U0ZrMjlLczJ6ZWc?oc=5) |
| Fierce Biotech | Endeavor’s threat to IPF incumbents increases after phase 2 win for Hedgehog inhibitor | [Source Link](https://news.google.com/rss/articles/CBMitwFBVV95cUxQQXhMakt6NVMyU2c4eTZWYjRXeFJreHZUNlFIM2ZHWWJPTlgyMkpWd1k3VGxsQm9sTWNRNjJkemlBMkdzUW5MLWlKdnYwY1BMVjBHQWhEazE5dlFxNU9ieW5xemIzSDNsTnFVQ3JPb295Xy1NOEsySWFQQXJTSXNSMlY0aG1VWkFmMkdEb1NGVDJzTGZXbmI0OVhSQ1o5V3EzSXFmdGx4TDIzRk5LTFlJaklCMk85aTA?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-09/endeavor-s-threat-to-ipf-incumbents-increases-after-phase-2-win-for-hedgehog*
